{"id":6020,"date":"2012-08-09T03:50:50","date_gmt":"2012-08-09T00:50:50","guid":{"rendered":"http:\/\/www.erzurumflas.com\/?p=6020"},"modified":"2012-08-09T03:50:50","modified_gmt":"2012-08-09T00:50:50","slug":"kolesterolde-sinir-190-oldu","status":"publish","type":"post","link":"https:\/\/www.erzhaber.com.tr\/?p=6020","title":{"rendered":"Kolesterolde s\u0131n\u0131r 190 oldu"},"content":{"rendered":"<div>\n<div>\n<p>SGK kolesterol ilac\u0131 al\u0131nabilmesi i\u00e7in seviyeyi 160\u2019tan 190\u2019a y\u00fckseltme karar\u0131na eczac\u0131 ve doktorlar sert tepki g\u00f6sterdi. Bu kararla vatanda\u015f\u0131n bu ila\u00e7lara ula\u015fmas\u0131n\u0131n daha da zorla\u015faca\u011f\u0131 belirtiliyor.<\/p>\n<\/div>\n<\/div>\n<div><img loading=\"lazy\" decoding=\"async\" src=\"http:\/\/www.hurriyet.com.tr\/p\/spacer.gif\" alt=\"\" width=\"578\" height=\"10\" \/><\/div>\n<div id=\"DivAdnetHaberDetay\">\n<div>\n<p>SOSYAL G\u00fcvenlik Kurumu\u2019nun (SGK), kolesterol ilac\u0131 al\u0131nabilmesi i\u00e7in seviyeyi 160\u2019tan 190\u2019a y\u00fckseltme karar\u0131na eczac\u0131 ve doktorlar sert tepki g\u00f6sterdi. T\u00fcm Eczac\u0131 \u0130\u015fverenler Sendikas\u0131 (TE\u0130S), bu durumun ciddi sa\u011fl\u0131k sorunlar\u0131 yarataca\u011f\u0131n\u0131 belirtirken, T\u00fcrk Tabipleri Birli\u011fi ise vatanda\u015f\u0131n art\u0131k sa\u011fl\u0131\u011fa daha fazla para harcayaca\u011f\u0131n\u0131 bildirdi.<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p><strong>65 ya\u015f \u00fcst\u00fc \u015fart\u0131<\/strong><\/p>\n<p>SGK, Sa\u011fl\u0131k Uygulama Tebli\u011fi\u2019nde (SUT) yapt\u0131\u011f\u0131 de\u011fi\u015fiklikle, kolesterol hastalar\u0131 i\u00e7in ilaca eri\u015fime s\u0131n\u0131rland\u0131rma getirdi. \u00d6nceki g\u00fcn y\u00fcr\u00fcrl\u00fc\u011fe giren uygulamaya g\u00f6re daha \u00f6nce ila\u00e7 kullanmayan kolesterol hastalar\u0131 ihtiya\u00e7 halinde ila\u00e7lar\u0131n\u0131 ancak uzman hekim raporuna g\u00f6re alabilecek. Ancak s\u00f6z konusu raporu alabilmesi i\u00e7in de hastan\u0131n bir hafta arayla iki defa tahlil yapt\u0131rmas\u0131, kolesterol de\u011ferinin yap\u0131lan iki tahlilde de 190\u2018\u0131n \u00fczerinde olmas\u0131 gerekiyor. B\u00f6ylece SGK yapt\u0131\u011f\u0131 de\u011fi\u015fiklikle daha \u00f6nce 160 olan s\u0131n\u0131r\u0131 190\u2019a \u00e7\u0131karm\u0131\u015f oldu. Hastan\u0131n kolesterol\u00fcn\u00fcn 190\u2019\u0131n alt\u0131nda olmas\u0131 durumunda ise ancak ailesinde y\u00fcksek tansiyon ve erken kalp hastal\u0131klar\u0131n\u0131n olmas\u0131 veya 65 ya\u015f \u00fcst\u00fc olmas\u0131 \u015fart\u0131 aranacak.<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Daha fazla katk\u0131 pay\u0131<\/strong><\/p>\n<p>T\u00fcrk Tabipleri Ba\u015fkan\u0131 \u00d6zdemir Aktan, SGK harcamalar\u0131nda ciddi a\u00e7\u0131k bulundu\u011funu, bu nedenle de ila\u00e7tan k\u0131s\u0131nt\u0131ya gidildi\u011fini s\u00f6yledi. Aktan, \u201cBu paket daha da daralacak. SGK yeni bir genelge yay\u0131nlad\u0131. Tamamlay\u0131c\u0131 Sa\u011fl\u0131k Sigortas\u0131 ad\u0131 alt\u0131nda bir sigorta \u00e7\u0131kard\u0131. Buna g\u00f6re hastalar sa\u011fl\u0131\u011fa eri\u015fim i\u00e7in daha fazla katk\u0131 ve kat\u0131l\u0131m pay\u0131 \u00f6deyecekler. Aksi halde s\u0131k\u0131nt\u0131 ya\u015fayacaklar\u201d dedi.<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Sa\u011fl\u0131k sorunlar\u0131 olu\u015facak<\/strong><\/p>\n<p>TE\u0130S Genel Ba\u015fkan\u0131 Nurten Saydan ise 190 de\u011ferinin \u00e7ok y\u00fcksek oldu\u011funu belirterek, \u015funlar\u0131 s\u00f6yledi: \u201c6 A\u011fustos \u00f6ncesi rapor alm\u0131\u015f hastalar\u0131n ilac\u0131 almalar\u0131nda herhangi bir sorun yok. 6 A\u011fustos\u2019tan itibaren kolesterol d\u00fc\u015f\u00fcr\u00fcc\u00fc ila\u00e7 kullanmas\u0131 gereken hastalar bu uygulamadan ma\u011fduriyet ya\u015fayacak. Zira SGK son de\u011fi\u015fiklikle vatanda\u015f\u0131n kolesterol\u00fc risk seviyesini ge\u00e7meden ilac\u0131n\u0131 \u00f6demeyecek.\u201d<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Risk seviyesini a\u015fmas\u0131 hastal\u0131klara yol a\u00e7ar<\/strong><\/p>\n<p>HASTANIN ila\u00e7 kullanabilmesi i\u00e7in LDL de\u011ferinin 190 mg\/dL \u00fcst\u00fc olmas\u0131 gerekti\u011fini vurgulayan Nurten Saydan, \u201cLDL sonucu 190 \u00e7\u0131kmaz ise hastan\u0131n ailesinde hastal\u0131k var m\u0131 diye bak\u0131lacak. Yani kurumun belirledi\u011fi \u00fc\u00e7 risk fakt\u00f6r\u00fc sorgulanacak. Ancak bilinmelidir ki, kolesterol\u00fcn risk seviyesini a\u015fmas\u0131 ciddi kalp damar sorunlar\u0131na neden olmakta, damar duvar\u0131nda biriken ve damar sertli\u011fine neden olan kolesterol koroner kalp hastal\u0131\u011f\u0131 kalp krizi, inme ve dola\u015f\u0131m hastal\u0131klar\u0131naneden olabilmektedir.\u201d<\/p>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>SGK kolesterol ilac\u0131 al\u0131nabilmesi i\u00e7in seviyeyi 160\u2019tan 190\u2019a y\u00fckseltme karar\u0131na eczac\u0131 ve doktorlar sert tepki g\u00f6sterdi. Bu kararla vatanda\u015f\u0131n bu ila\u00e7lara ula\u015fmas\u0131n\u0131n daha da zorla\u015faca\u011f\u0131 belirtiliyor. SOSYAL G\u00fcvenlik Kurumu\u2019nun (SGK), kolesterol ilac\u0131 al\u0131nabilmesi i\u00e7in seviyeyi 160\u2019tan 190\u2019a y\u00fckseltme karar\u0131na eczac\u0131 ve doktorlar sert tepki g\u00f6sterdi. T\u00fcm Eczac\u0131 \u0130\u015fverenler Sendikas\u0131 (TE\u0130S), bu durumun ciddi sa\u011fl\u0131k sorunlar\u0131 [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":6022,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[14],"tags":[],"class_list":["post-6020","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-saglik"],"_links":{"self":[{"href":"https:\/\/www.erzhaber.com.tr\/index.php?rest_route=\/wp\/v2\/posts\/6020","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.erzhaber.com.tr\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.erzhaber.com.tr\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.erzhaber.com.tr\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.erzhaber.com.tr\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=6020"}],"version-history":[{"count":0,"href":"https:\/\/www.erzhaber.com.tr\/index.php?rest_route=\/wp\/v2\/posts\/6020\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.erzhaber.com.tr\/index.php?rest_route=\/wp\/v2\/media\/6022"}],"wp:attachment":[{"href":"https:\/\/www.erzhaber.com.tr\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=6020"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.erzhaber.com.tr\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=6020"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.erzhaber.com.tr\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=6020"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}